Jaffetilchin Investment Partners’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-73
Closed -$3.09K – 412
2024
Q3
$3.09K Buy
+73
New +$3.83K ﹤0.01% 1121
2023
Q4
– Sell
-2,912
Closed -$248K – 346
2023
Q3
$248K Buy
2,912
+48
+2% +$4.55K 0.03% 293
2023
Q2
$313K Hold
2,864
– – 0.03% 276
2023
Q1
$238K Sell
2,864
-148
-5% -$13.9K 0.03% 317
2022
Q4
$310K Sell
3,012
-40
-1% -$4.61K 0.04% 269
2022
Q3
$323K Sell
3,052
-1,230
-29% -$135K 0.04% 235
2022
Q2
$470K Sell
4,282
-35
-0.8% -$3.46K 0.06% 192
2022
Q1
$369K Sell
4,317
-2,657
-38% -$276K 0.04% 234
2021
Q4
$853K Sell
6,974
-1,624
-19% -$180K 0.08% 155
2021
Q3
$987K Sell
8,598
-168
-2% -$17.8K 0.11% 133
2021
Q2
$850K Buy
8,766
+5,921
+208% +$514K 0.06% 197
2021
Q1
$210K Buy
+2,845
New +$211K 0.02% 332
2018
Q4
– Sell
-3,684
Closed -$202K – 260
2018
Q3
$202K Hold
3,684
– – 0.04% 290
2018
Q2
$216K Hold
3,684
– – 0.05% 269
2018
Q1
$209K Sell
3,684
-1,058
-22% -$57.5K 0.05% 306
2017
Q4
$234K Hold
4,742
– – 0.08% 209
2017
Q3
$217K Buy
+4,742
New +$181K 0.05% 270

Other funds holding AMN

Jaffetilchin Investment Partners's AMN Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of AMN Healthcare (AMN) in Q4 2024, closing a stake of 73 shares — an estimated $3.09K sold.

Jaffetilchin Investment Partners first reported a position in AMN in Q3 2017 and held it in 17 quarters. The position peaked at $987K in Q3 2021. 278 funds tracked by Wall St. Rank hold AMN as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining AMN Healthcare position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 73 AMN Healthcare shares in Q4 2024, an estimated $3.09K.
  • Jaffetilchin Investment Partners first reported a position in AMN Healthcare in Q3 2017 and held it in 17 quarters.
  • Jaffetilchin Investment Partners's AMN Healthcare position peaked at $987K in Q3 2021.
  • 278 funds tracked by Wall St. Rank held AMN Healthcare as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.